Table 4.
Bivariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|
RR | P Value | RR | P Value | |
Any adverse event | 1.0 | .933 | 1.0 | .793 |
Any severe adverse event | 1.0 | .808 | 0.9 | .525 |
Death | 3.4 | .132 | 4.5 | .098 |
Thromboembolic event (DVT/PE) | 1.1 | .825 | 0.9 | .854 |
Surgical site infection | 0.7 | .319 | 0.6 | .178 |
Sepsis | 2.1 | .256 | 2.2 | .228 |
Myocardial infarction | 5.1 | .021 | 7.6 | .015 |
Return to the operating room | 0.8 | .501 | 0.8 | .517 |
Wound dehiscence | 7.7 | .008 | 6.9 | .007 |
Any minor adverse event | 2.1 | .017 | 2.4 | .009 |
Urinary tract infection | 1.6 | .396 | 2.08 | .211 |
Pneumonia | 1.9 | .418 | 1.8 | .472 |
Blood transfusion | 4.1 | .003 | 4.5 | .004 |
Readmission | 1.3 | .277 | 1.5 | .134 |
aOwing to multiple comparisons, a Bonferroni correction was used. Bolding indicates statistical significance (P < .004). DVT, deep vein thrombosis; PE, pulmonary embolism; RR, relative risk.